AUG 31, 2016 02:19 PM PDT

Explaining Slow Recovery from Bone Marrow Transplants

WRITTEN BY: Kara Marker
Replacing faulty stem cells in the bone marrow with a transplant is one way to treat some bone cancers, but the immune recovery process following the procedure is often tedious, leaving a person vulnerable to other infections. With the discovery of a molecule involved in this immune recovery, scientists from the University of Birmingham may hold the key to improving recovery following bone marrow transplant surgeries. 
A plot of immature T cells in the thymus: T cell progenitors in red.
A molecule called Lymphotoxin beta receptor was found in a recent Journal of Immunology study to regulate the influx of T cell progenitors into the thymus, a vital lymphoid gland that nurtures T cells into mature lymphocytes to be released into the bloodstream to participate in adaptive immune responses. The role thymus plays in the development of these immune cells is the reason they are called “T” cells.

Both when an individual is healthy and when an individual is experiencing immune recovery, the Lymphotoxin beta receptor is required for T cell entry into the thymus. In theory, the receptor could be inhibiting or reducing the amount of T cells allowed to enter the thymus after a bone marrow transplantation. In the words of Birmingham professor Graham Anderson: “as if the doorway to the thymus is closed.”

In their studies, Birmingham scientists used mouse models to study the role of Lymphotoxin beta receptor in regulating the thymus. “Identifying molecular regulators that can ‘prop open’ the door and allow these cells to enter and mature,” Anderson said, “could well be a means to help reboot the immune system.”

In an effort to manually stimulate the Lymphotoxin beta receptor to allow more T cell progenitors access to the the thymus, researchers used antibody-mediated stimulation in the mice. The stimulation successfully enhanced initial thymus recovery and also “boosted the number of transplant-derived T cells.”

According to the study scientists, cancer patients receiving bone marrow often take years to recover their T cell population. With the right future studies, bone marrow transplant patients could soon be benefiting from drugs that stimulate their Lymphotoxin beta receptors. In fact, the same group from Birmingham will soon start examining in vitro human samples of thymus tissue to further investigate the role of Lymphotoxin beta receptor in human thymus regulation.

More about bone marrow transplants 

Bone marrow tissue contains stem cells that develop into white blood cells, like T cells, red blood cells, and platelets. Bone marrow transplants are done to treat different conditions such as leukemia and other blood cancers, aplastic anemia and other diseases that cause bone marrow failure, and other immune disorders and genetic diseases.
 


Sources: Healthline, MedlinePlus, Be The Match, University of Birmingham
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAY 10, 2018
Immunology
MAY 10, 2018
New Biomarker for Lung Cancer Diagnosis
Lung cancer is the most common cause of death from cancer for both genders and for people all over the globe. This is largely due to the lack of diagnostic...
MAY 23, 2018
Immunology
MAY 23, 2018
Isolating The Source of Interleukin-25 In Common Respiratory Disorders
The latest discovery from the Perelman School of Medicine at the University of Pennsylvania examined the mechanisms behind how the immune system responds t...
MAY 24, 2018
Immunology
MAY 24, 2018
Brain and Gut Link in Multiple Sclerosis
Scientists have discovered a new molecular pathway connecting brain and gut that if learned how to control, may be able to treat Multiple Sclerosis and oth...
JUN 06, 2018
Immunology
JUN 06, 2018
Why are women more prone to autoimmunity than men?
For a long time scientists have been trying to understand why females are more likely than males to develop autoimmune diseases. From the University of Got...
AUG 20, 2018
Immunology
AUG 20, 2018
Photosensitivity Linked to Immune Cell Dysfunction
The Langerhans cells of the immune system activate cytokines essential for skin protection when exposed to UV that is functional in photosensitive individuals....
SEP 05, 2018
Immunology
SEP 05, 2018
B Cells Contribute to Brain Lesions in Multiple Sclerosis
B cells lead to T cell activation resulting in damage to the myelin sheath and brain cells in multiple sclerosis pathogenesis....
Loading Comments...